Congenital Heart Disease Studies
Congenital Heart Disease Studies is a research topic within Epidemiology. Science Explorer counts 63k research works in it since 1950. 11.0% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the epidemiology, management, and outcomes of congenital heart disease, covering topics such as cardiac surgery, pulmonary valve replacement, neurodevelopmental outcomes, adult congenital heart disease, mortality risk, fetal cardiac disease, ventricular function, echocardiogram guidelines, and the Fontan procedure.
- Congenital Heart Disease
- Cardiac Surgery
- Pulmonary Valve Replacement
- Neurodevelopmental Outcomes
- Adult Congenital Heart Disease
- Mortality Risk
- Fetal Cardiac Disease
- Ventricular Function
- Echocardiogram Guidelines
- Fontan Procedure
- Research works
- 63k fractional, since 1950
- In the world top 10%
- 6.9k per year above
- Top-10% rate
- 11.0% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +28% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Congenital Heart Disease Studies research?
By volume, the United States and China publish the most (3.5k and 988 works in 2022–2025).
By volume, 2022–2025
- 1 United States 3.5k works
- 2 China 988 works
- 3 India 623 works
- 4 Japan 567 works
- 5 United Kingdom 502 works
- 6 Germany 464 works
- 7 Italy 407 works
- 8 Canada 348 works
- 9 Brazil 299 works
- 10 Türkiye 269 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Congenital Heart Disease Studies research?
By volume in 2022–2025, Boston Children's Hospital publishes the most Congenital Heart Disease Studies research, followed by Children's Hospital of Philadelphia and All India Institute of Medical Sciences.
By volume, 2022–2025
- 1 Boston Children's HospitalUnited States 82 works
- 2 Children's Hospital of PhiladelphiaUnited States 68 works
- 3 All India Institute of Medical SciencesIndia 63 works
- 4 Cincinnati Children's Hospital Medical CenterUnited States 57 works
- 5 Harvard UniversityUnited States 56 works
- 6 Mayo Clinic in ArizonaUnited States 52 works
- 7 Cleveland ClinicUnited States 50 works
- 8 Baylor College of MedicineUnited States 49 works
- 9 Mayo ClinicUnited States 47 works
- 10 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 44 works
Who are the leading researchers in Congenital Heart Disease Studies?
The most-cited researchers publishing on Congenital Heart Disease Studies include H. Vincent Poor, Winfried März and E. Murat Tuzcu.
- 1 H. Vincent Poor United States 9.5k citations
- 2 Winfried März Germany 5.2k citations
- 3 E. Murat Tuzcu United States 4.7k citations
- 4 Stephan Windecker Switzerland 4.2k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Congenital Heart Disease Studies research done?
The largest centres of Congenital Heart Disease Studies research in 2022–2025 are London (United Kingdom), Beijing (China), Boston (United States) and Philadelphia (United States). Among places with at least 20 works in it, it is an unusually large share of all research in Chicago and Rochester.
Largest cities, 2022–2025
- 1 London United Kingdom 208 works
- 2 Beijing China 174 works
- 3 Boston United States 169 works
- 4 Philadelphia United States 162 works
- 5 Houston United States 143 works
- 6 New York United States 135 works
- 7 Tokyo Japan 125 works
- 8 Toronto Canada 121 works
- 9 Shanghai China 115 works
- 10 Istanbul Türkiye 103 works
Where it is the local speciality
- ChicagoUS · 23.1 works35×
- RochesterUS · 47.4 works11×
Location quotient: how much more of its research is in Congenital Heart Disease Studies than the world average.
Where is the best place to study Congenital Heart Disease Studies?
Among universities, judged by research, University of Colorado Denver, Baylor College of Medicine and Harvard University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | University of Colorado DenverUnited States | 57.2 | 12.3% | 8.5× | 30 | +77.4% |
| 2 | Baylor College of MedicineUnited States | 56.7 | 7.6% | 11.4× | 49 | +27.7% |
| 3 | Harvard UniversityUnited States | 55.9 | 16.6% | 4.1× | 56 | +21.5% |
| 4 | University of PaduaItaly | 53.8 | 16.7% | 4.2× | 36 | +54.9% |
| 5 | Medical University of South CarolinaUnited States | 52.6 | 11.6% | 9.8× | 24 | -2.6% |
| 6 | University of IowaUnited States | 51.1 | 23.4% | 2.6× | 12 | +133.6% |
| 7 | All India Institute of Medical SciencesIndia | 50.6 | 1.7% | 9.5× | 63 | +51.5% |
| 8 | University of TorontoCanada | 48.7 | 20.0% | 1.9× | 30 | +16.5% |
| 9 | Semmelweis UniversityHungary | 48.6 | 23.2% | 3.9× | 8 | +63.2% |
| 10 | University of PennsylvaniaUnited States | 48.1 | 15.6% | 3.9× | 39 | +9.6% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Congenital Heart Disease Studies research growing?
Output in 2018–2022 was 28% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Congenital Heart Disease Studies.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.